Artificial intelligence is poised to revolutionize healthcare by offering faster diagnostics, more targeted treatments, and improved communication between medical professionals and patients. Companies like Health Partners in the UK, led by CEO Axel Heit, anticipate a significant role for AI in reading scans with greater accuracy and speed than humans. Meanwhile, initiatives such as the European project TRUSTroke, coordinated by Anna Sala at Vall d’Hebron Barcelona Hospital Campus, are leveraging AI to optimize stroke treatment.
AI is already demonstrating its value in personalized care and patient interaction. For instance, tools that transcribe patient consultations enable doctors to maintain eye contact, while AI-powered chatbots like Lola, developed by Vall d’Hebron with AstraZeneca and Tucuvi, provide personalized tracking for heart failure and COPD patients. Lola prompts patients to answer questions about their health via phone, with AI analyzing responses in the cloud and recommending follow-up appointments when necessary, thereby reducing unnecessary hospital visits and environmental impact.
In the realm of diagnostics, the FDA has cleared several new AI-powered devices. Cosmo Artificial Intelligence and Medtronic received a Special 510(k) clearance on May 30, 2026, for the next-generation GI Genius Module 300 and ColonPRO software, enhancing polyp detection in colonoscopies. Philips also received FDA 510(k) clearance for its Elevate Plus software upgrade, which brings AI-powered decision support for breast and thyroid imaging directly onto ultrasound carts, automating abdominal measurements with over 93% accuracy and potentially reducing scanning time by up to 30%.
Furthermore, AI is being deployed for autonomous care pathways. Flok Health recently raised $12.5 million in Series A funding to expand its AI physiotherapist service across the UK, which has regulatory approval from the NHS to triage, treat, and discharge patients for back pain without human intervention. This system, which is available to over 2.4 million patients, has shown that more than 80% of patients rate the AI clinic as good or better than in-person physiotherapy, saving an average of 856 hours of clinical time per month at one NHS trust. Flok Health plans to extend this model to hip, knee, and pelvic-health conditions. Separately, physicians are rapidly adopting AI-powered apps like OpenEvidence, a medical chatbot that uses high-quality research to assist with diagnosis and treatment, with over half of US physicians now regular users, performing 30 million consultations last month.
